E.E. Geduld’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

E.E. Geduld’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$38K	Sell	100,000 -25,000	-20%	-$8.46K	0.02%	142
2016 Q3	$34K	Hold	125,000	–	–	0.03%	155
2016 Q2	$30K	Hold	125,000	–	–	0.04%	133
2016 Q1	$14K	Hold	125,000	–	–	0.02%	139
2015 Q4	$14K	Hold	125,000	–	–	0.01%	162
2015 Q3	$24K	Sell	125,000 -25,000	-17%	-$8.5K	0.02%	173
2015 Q2	$105K	Buy	150,000 +50,000	+50%	+$34.6K	0.07%	212
2015 Q1	$68K	Hold	100,000	–	–	0.05%	211
2014 Q4	$79K	Sell	100,000 -50,000	-33%	-$34.2K	0.04%	189
2014 Q3	$70K	Buy	150,000 +50,000	+50%	+$24.3K	0.05%	193
2014 Q2	$50K	Hold	100,000	–	–	0.03%	250
2014 Q1	$31K	Hold	100,000	–	–	0.02%	261
2013 Q4	$34K	Sell	100,000 -50,000	-33%	-$60.4K	0.02%	274
2013 Q3	$303K	Hold	150,000	–	–	0.18%	134
2013 Q2	$285K	Buy	+150,000	New	+$264K	0.2%	128

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

E.E. Geduld's GCVRZ Position: Q4 2016 in Review

E.E. Geduld reduced its Sanofi Contingent Value Rights (GCVRZ) stake by 20% in Q4 2016, selling an estimated $8.46K and leaving 100,000 shares worth $38K. The position accounts for 0.02% of the portfolio, ranked #142.

E.E. Geduld first reported a position in GCVRZ in Q2 2013 and has held it in 15 quarters since. The position peaked at $303K in Q3 2013. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

E.E. Geduld held 100,000 shares of Sanofi Contingent Value Rights worth $38K as of Q4 2016.
E.E. Geduld sold 25,000 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $8.46K.
Sanofi Contingent Value Rights made up 0.02% of E.E. Geduld's portfolio in Q4 2016, its #142 holding.
E.E. Geduld first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 15 quarters since.
E.E. Geduld's Sanofi Contingent Value Rights position peaked at $303K in Q3 2013.
120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.